MPX Bioceutical Corporation Archives

Green Market Report

Home
News Briefs
Spotlight
Videos
Events
- Crain’s Cleveland Business Cannabis Summit
- Upcoming Events
Awards
- 2023 Notable Leaders in Cannabis

Adam JacksonMay 16, 2023

iAnthus is grappling with several legal battles that pose risks to its operational future.

William SumnerNovember 30, 2018

MPX Bioceutical Corporation MPX Bioceutical Corporation (CSE: MPX) reported its financial results for the second quarter ended on September 30, 2018. MPX recorded revenue of CAD$14.7 million, up from CAD$4.4 million in the same quarter during the previous year. The increase in revenue was attributed to wholesale operations and the company’s management of four cannabis […]

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis

Recent Tweets

Company

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: MPX Bioceutical Corporation

iAnthus Q1 Revenue Drops as Legal Woes Continue to Mount

Earnings Roundup: , MPX Bioceutical, Plus Products, Emerald Health Therapeutics

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox